Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.25 Billion CNY | 48.89% |
| 2022 | -2.46 Billion CNY | 22.0% |
| 2021 | -3.15 Billion CNY | -579.18% |
| 2020 | -464.78 Million CNY | 39.53% |
| 2019 | -768.6 Million CNY | -98.06% |
| 2018 | -388.07 Million CNY | 50.5% |
| 2017 | -783.92 Million CNY | 52.6% |
| 2016 | -1.65 Billion CNY | -74.92% |
| 2015 | -945.42 Million CNY | -11.04% |
| 2014 | -851.42 Million CNY | -22.64% |
| 2013 | -694.23 Million CNY | 27.59% |
| 2012 | -958.77 Million CNY | -7.79% |
| 2011 | -889.47 Million CNY | 11.55% |
| 2010 | -1 Billion CNY | 13.57% |
| 2009 | -1.16 Billion CNY | -14310.81% |
| 2008 | -8.07 Million CNY | -2029.95% |
| 2007 | -379.08 Thousand CNY | -105.39% |
| 2006 | 7.02 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.38 Billion CNY | -9.88% |
| 2024 Q2 | -908.04 Million CNY | 34.34% |
| 2024 Q3 | -967.5 Million CNY | -5.98% |
| 2023 Q4 | -1.25 Billion CNY | 19.1% |
| 2023 Q3 | -1.55 Billion CNY | 7.19% |
| 2023 Q2 | -1.67 Billion CNY | 25.04% |
| 2023 FY | -1.25 Billion CNY | 48.89% |
| 2023 Q1 | -2.23 Billion CNY | 9.19% |
| 2022 Q1 | -3.21 Billion CNY | -1.96% |
| 2022 FY | -2.46 Billion CNY | 22.0% |
| 2022 Q4 | -2.46 Billion CNY | 18.35% |
| 2022 Q3 | -3.01 Billion CNY | 7.97% |
| 2022 Q2 | -3.27 Billion CNY | -1.81% |
| 2021 Q1 | -577.33 Million CNY | -24.21% |
| 2021 FY | -3.15 Billion CNY | -579.18% |
| 2021 Q4 | -3.15 Billion CNY | 0.58% |
| 2021 Q3 | -3.17 Billion CNY | -3.24% |
| 2021 Q2 | -3.07 Billion CNY | -432.73% |
| 2020 Q4 | -464.78 Million CNY | -18.37% |
| 2020 Q1 | -682.1 Million CNY | 11.25% |
| 2020 FY | -464.78 Million CNY | 39.53% |
| 2020 Q3 | -392.64 Million CNY | 20.98% |
| 2020 Q2 | -496.89 Million CNY | 27.15% |
| 2019 Q2 | -102.3 Million CNY | 86.5% |
| 2019 Q1 | -757.53 Million CNY | -95.21% |
| 2019 FY | -768.6 Million CNY | -98.06% |
| 2019 Q4 | -768.6 Million CNY | -13.31% |
| 2019 Q3 | -678.29 Million CNY | -563.04% |
| 2018 Q4 | -388.07 Million CNY | -34.69% |
| 2018 Q3 | -288.12 Million CNY | 65.21% |
| 2018 FY | -388.07 Million CNY | 50.5% |
| 2018 Q2 | -828.1 Million CNY | 8.82% |
| 2018 Q1 | -908.22 Million CNY | -15.86% |
| 2017 Q3 | -554.16 Million CNY | 35.59% |
| 2017 Q2 | -860.32 Million CNY | 28.67% |
| 2017 FY | -783.92 Million CNY | 52.6% |
| 2017 Q4 | -783.92 Million CNY | -41.46% |
| 2017 Q1 | -1.2 Billion CNY | 27.07% |
| 2016 FY | -1.65 Billion CNY | -74.92% |
| 2016 Q4 | -1.65 Billion CNY | 2.43% |
| 2016 Q1 | -1.21 Billion CNY | -29.02% |
| 2016 Q3 | -1.69 Billion CNY | -28.89% |
| 2016 Q2 | -1.31 Billion CNY | -7.81% |
| 2015 Q4 | -945.42 Million CNY | -147.43% |
| 2015 FY | -945.42 Million CNY | -11.04% |
| 2015 Q3 | -382.1 Million CNY | 27.85% |
| 2015 Q1 | -608.19 Million CNY | 28.57% |
| 2015 Q2 | -529.59 Million CNY | 12.92% |
| 2014 Q4 | -851.42 Million CNY | -62.9% |
| 2014 Q1 | -787.37 Million CNY | -13.42% |
| 2014 Q3 | -522.65 Million CNY | 33.87% |
| 2014 FY | -851.42 Million CNY | -22.64% |
| 2014 Q2 | -790.3 Million CNY | -0.37% |
| 2013 Q1 | -839.92 Million CNY | 12.4% |
| 2013 FY | -694.23 Million CNY | 27.59% |
| 2013 Q4 | -694.23 Million CNY | -8.51% |
| 2013 Q3 | -639.78 Million CNY | -10.34% |
| 2013 Q2 | -579.82 Million CNY | 30.97% |
| 2012 Q4 | -958.77 Million CNY | 1.85% |
| 2012 FY | -958.77 Million CNY | -7.79% |
| 2012 Q1 | -970.34 Million CNY | -9.09% |
| 2012 Q2 | -896.38 Million CNY | 7.62% |
| 2012 Q3 | -976.86 Million CNY | -8.98% |
| 2011 Q1 | -884.58 Million CNY | 12.04% |
| 2011 Q3 | -945.28 Million CNY | -27.46% |
| 2011 FY | -889.47 Million CNY | 11.55% |
| 2011 Q4 | -889.47 Million CNY | 5.9% |
| 2011 Q2 | -741.61 Million CNY | 16.16% |
| 2010 Q2 | -1.09 Billion CNY | 4.6% |
| 2010 Q1 | -1.15 Billion CNY | 1.09% |
| 2010 Q4 | -1 Billion CNY | 1.67% |
| 2010 FY | -1 Billion CNY | 13.57% |
| 2010 Q3 | -1.02 Billion CNY | 6.85% |
| 2009 Q3 | -1.19 Billion CNY | -2212.74% |
| 2009 FY | -1.16 Billion CNY | -14310.81% |
| 2009 Q2 | -51.71 Million CNY | 0.0% |
| 2009 Q4 | -1.16 Billion CNY | 2.72% |
| 2008 Q4 | -8.07 Million CNY | 0.0% |
| 2008 FY | -8.07 Million CNY | -2029.95% |
| 2007 FY | -379.08 Thousand CNY | -105.39% |
| 2006 FY | 7.02 Million CNY | 0.0% |